JP2014520849A5 - - Google Patents

Download PDF

Info

Publication number
JP2014520849A5
JP2014520849A5 JP2014520238A JP2014520238A JP2014520849A5 JP 2014520849 A5 JP2014520849 A5 JP 2014520849A5 JP 2014520238 A JP2014520238 A JP 2014520238A JP 2014520238 A JP2014520238 A JP 2014520238A JP 2014520849 A5 JP2014520849 A5 JP 2014520849A5
Authority
JP
Japan
Prior art keywords
metal
group
bisphosphonate
nanoparticles according
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014520238A
Other languages
English (en)
Japanese (ja)
Other versions
JP6049712B2 (ja
JP2014520849A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/045954 external-priority patent/WO2013009701A2/en
Publication of JP2014520849A publication Critical patent/JP2014520849A/ja
Publication of JP2014520849A5 publication Critical patent/JP2014520849A5/ja
Application granted granted Critical
Publication of JP6049712B2 publication Critical patent/JP6049712B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014520238A 2011-07-08 2012-07-09 抗癌治療及び画像化並びに骨障害治療のための金属ビスホスホネートナノ粒子 Active JP6049712B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161505806P 2011-07-08 2011-07-08
US61/505,806 2011-07-08
PCT/US2012/045954 WO2013009701A2 (en) 2011-07-08 2012-07-09 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders

Publications (3)

Publication Number Publication Date
JP2014520849A JP2014520849A (ja) 2014-08-25
JP2014520849A5 true JP2014520849A5 (enExample) 2015-08-27
JP6049712B2 JP6049712B2 (ja) 2016-12-21

Family

ID=47506842

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014520238A Active JP6049712B2 (ja) 2011-07-08 2012-07-09 抗癌治療及び画像化並びに骨障害治療のための金属ビスホスホネートナノ粒子

Country Status (4)

Country Link
US (3) US9693957B2 (enExample)
EP (2) EP3494974B1 (enExample)
JP (1) JP6049712B2 (enExample)
WO (1) WO2013009701A2 (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5863670B2 (ja) 2010-01-19 2016-02-17 ノースウェスタン ユニバーシティ 核酸および/または他の構成要素を含有している合成ナノ構造体
JP6049712B2 (ja) 2011-07-08 2016-12-21 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒルThe University Of North Carolina At Chapel Hill 抗癌治療及び画像化並びに骨障害治療のための金属ビスホスホネートナノ粒子
HK1166436A2 (en) * 2011-09-08 2012-10-26 Ybs Graphene Company Limited A method of forming a negative ion emitting product and a product formed by such method
CN105579582A (zh) 2013-07-25 2016-05-11 埃克西奎雷股份有限公司 用于预防和治疗用途的作为免疫刺激剂的基于球形核酸的构建体
CN105873569B (zh) * 2013-11-06 2020-07-28 芝加哥大学 用于化疗剂、核酸和光敏剂的递送或共递送的纳米级载体
CN112107693B (zh) 2013-12-03 2023-05-26 西北大学 脂质体颗粒、制备所述脂质体颗粒的方法以及其用途
US10118169B2 (en) 2014-03-28 2018-11-06 The University Of Chicago Chiral ligand-based metal-organic frameworks for broad-scope asymmetric catalysis
WO2015149072A1 (en) 2014-03-28 2015-10-01 The University Of Chicago Metal-organic frameworks containing nitrogen-donor ligands for efficient catalytic organic transformations
US10413565B2 (en) 2014-04-30 2019-09-17 Northwestern University Nanostructures for modulating intercellular communication and uses thereof
CA2953216C (en) * 2014-06-04 2020-12-22 Exicure, Inc. Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
AU2015301462B2 (en) * 2014-08-14 2020-02-27 L.E.A.F. Holdings Group Llc Liposome encapsulated affinity drug
US10588564B2 (en) 2014-09-30 2020-03-17 Moein Health, LLC Method and kit for diagnosing and treating neoplastic tissue
BR112017007012A2 (pt) 2014-10-06 2018-03-06 Exicure Inc compostos anti-tnf
JP6731404B2 (ja) 2014-10-14 2020-07-29 ザ ユニバーシティ オブ シカゴThe University Of Chicago 光線力学療法、x線誘起光線力学療法、放射線療法、化学療法、免疫療法、及びこれらの任意の組み合わせのためのナノ粒子
US10806694B2 (en) 2014-10-14 2020-10-20 The University Of Chicago Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof
WO2016085986A1 (en) 2014-11-24 2016-06-02 Northwestern University High density lipoprptein nanoparticles for inflammation
JP6378837B2 (ja) 2015-04-24 2018-08-22 デューク・ユニヴァーシティ イメージング剤として有用なビスホスホネート又はピロホスフェートを有する金属錯体
CN107087397B (zh) 2015-09-30 2020-12-18 杜克大学 用于磁共振成像的造影剂
RU2657833C2 (ru) * 2015-12-01 2018-06-15 Общество С Ограниченной Ответственностью "Остерос Биомедика" Стабилизированная лекарственная форма конъюгата этидроната с цитарабином и её применение
US11672866B2 (en) * 2016-01-08 2023-06-13 Paul N. DURFEE Osteotropic nanoparticles for prevention or treatment of bone metastases
WO2017174969A1 (en) * 2016-04-08 2017-10-12 The University Of Birmingham Novel nanonization
EP3445409B1 (en) * 2016-04-22 2020-04-29 Duke University Manganese complexes with substituted bisphosphonates useful as imaging and therapeutic agents
US11246877B2 (en) 2016-05-20 2022-02-15 The University Of Chicago Nanoparticles for chemotherapy, targeted therapy, photodynamic therapy, immunotherapy, and any combination thereof
EA030671B1 (ru) 2016-07-20 2018-09-28 Общество С Ограниченной Ответственностью "Остерос Биомедика" Препарат для лечения костных поражений, вызванных злокачественными новообразованиями
WO2018113663A1 (en) * 2016-12-19 2018-06-28 The Chinese University Of Hong Kong Injectable hydrogels that promote mineralization and afford sustained release of bioactive ions
US11696954B2 (en) 2017-04-28 2023-07-11 Exicure Operating Company Synthesis of spherical nucleic acids using lipophilic moieties
MX2020000387A (es) 2017-07-13 2020-08-17 Univ Northwestern Método general y directo para preparar nanopartículas de estructura organometálica funcionalizadas con oligonucleotidos.
US11826426B2 (en) 2017-08-02 2023-11-28 The University Of Chicago Nanoscale metal-organic layers and metal-organic nanoplates for x-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof
US20190314324A1 (en) * 2018-04-13 2019-10-17 The University Of Chicago Combination of micheliolide derivatives or nanoparticles with ionizing radiation and checkpoint inhibitors for cancer therapy
WO2020068798A1 (en) 2018-09-24 2020-04-02 Guo Jimin Living mammalian cells modified with functional modular nanoparticles
WO2020081581A1 (en) * 2018-10-16 2020-04-23 The Regents Of The University Of Colorado, A Body Corporate Chemiluminescent and fluorescent nanoparticle for optical imaging of cancer
WO2020176716A1 (en) 2019-02-28 2020-09-03 Brinker C Jeffrey Modular metal–organic polyhedra superassembly compositions
US12319711B2 (en) 2019-09-20 2025-06-03 Northwestern University Spherical nucleic acids with tailored and active protein coronae
US20220370372A1 (en) * 2019-09-27 2022-11-24 Greenmark Biomedical Inc. Bisphosphonate loaded starch nanoparticle
US12378560B2 (en) 2019-10-29 2025-08-05 Northwestern University Sequence multiplicity within spherical nucleic acids
US20230001396A1 (en) * 2019-11-14 2023-01-05 Board Of Regents, The University Of Texas System Compositions and methods for controlled delivery and protection of therapeutic agents
CN111420071A (zh) * 2020-03-27 2020-07-17 苏州欣影生物医药技术有限公司 一种纳米颗粒磁共振造影剂、制备方法及应用
DE102020116859A1 (de) 2020-06-26 2021-12-30 Pharma Development Holding Gmbh Liposomen
IT202000021292A1 (it) * 2020-09-09 2022-03-09 Consiglio Nazionale Ricerche Composizione in forma di polvere a base di microparticelle incorporanti nanoparticelle per la veicolazione di composti terapeutici/diagnostici
KR102514126B1 (ko) * 2020-12-24 2023-03-24 가톨릭대학교 산학협력단 히알루론산 나노입자를 유효성분으로 함유하는 전이성 골종양 광역학 치료용 조성물
CN114230610B (zh) * 2021-11-26 2023-05-23 西南医科大学附属医院 放射性标记物、其前体化合物、及制法和应用
WO2023107920A1 (en) * 2021-12-07 2023-06-15 The Trustees Of The University Of Pennsylvania Anisamide-containing lipids and compositions and methods of use thereof
CN115501202B (zh) * 2022-10-12 2023-05-19 北京大学 一种递送过渡态唾液酸转移酶抑制剂的核壳纳米粒子及其制备方法和应用
AU2024272079A1 (en) * 2023-05-16 2026-01-15 Magvitae Innovations Inc A novel non-stoichiometric multi-element adjuvant (nsma) and composition thereof
IT202300015396A1 (it) * 2023-07-21 2025-01-21 Torino Politecnico Nanoparticelle rivestite e loro uso per il trasporto di agenti terapeutici e diagnostici
WO2025077898A1 (en) * 2023-10-13 2025-04-17 The Chinese University Of Hong Kong A therapeutic nucleic acid-encased nanoworm for gene delivery and endosomal escape

Family Cites Families (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61351A (en) 1980-10-27 1983-12-30 Yeda Res & Dev Organometallic polymers,their preparation and compositions of co-ordination compounds containing them
US5147806A (en) 1988-04-29 1992-09-15 Igen, Inc. Method and apparatus for conducting electrochemiluminescence measurements
US5213788A (en) 1988-09-29 1993-05-25 Ranney David F Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement
DE69118188T2 (de) 1990-07-26 1996-10-31 Monsanto Co., St. Louis, Mo. Verfahren zur herstellung vernetzter polyamine
US6013638A (en) 1991-10-02 2000-01-11 The United States Of America As Represented By The Department Of Health And Human Services Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
US5858784A (en) 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
US5871710A (en) 1992-09-04 1999-02-16 The General Hospital Corporation Graft co-polymer adducts of platinum (II) compounds
US5591730A (en) * 1993-10-12 1997-01-07 The Regents Of The University Of California Inhibition of urinary calculi growth
US5641623A (en) 1995-01-04 1997-06-24 Martin; Mark T. Electrochemiluminescence assay
US20010003647A1 (en) 1995-06-07 2001-06-14 Ji Sun Coreatant-including electrochemiluminescent compounds, methods, systems and kits utilizing same
US6022737A (en) 1995-11-02 2000-02-08 Amgen Inc. Formulations for non-viral in vivo transfection in the lungs
US5648508A (en) 1995-11-22 1997-07-15 Nalco Chemical Company Crystalline metal-organic microporous materials
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
HU224918B1 (en) 1997-01-24 2006-04-28 Conpharma As Gemcitabine derivatives, process for their preparation and pharmaceutical compositions containing them
US6180082B1 (en) 1997-11-24 2001-01-30 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method to enhance tissue accumulation of radiolabeled compounds
US6984400B2 (en) 1998-07-14 2006-01-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treating restenosis using bisphosphonate nanoparticles
US6818227B1 (en) 1999-02-08 2004-11-16 Alza Corporation Liposome composition and method for administration of a radiosensitizer
WO2000048572A1 (en) 1999-02-18 2000-08-24 Supergen, Inc Phosphocholine linked prodrug derivatives
US20020064520A1 (en) 1999-08-19 2002-05-30 Yanina Rozenberg Targeted artificial gene delivery
DK1221955T3 (da) 1999-09-25 2006-01-30 Univ Iowa Res Found Immunstimulerende nukleinsyre
US6602932B2 (en) 1999-12-15 2003-08-05 North Carolina State University Nanoparticle composites and nanocapsules for guest encapsulation and methods for synthesizing same
AU2001251432A1 (en) * 2000-04-07 2001-10-23 The Board Of Regents Of The University Of Texas System Unique compositions of zwitterionic phospholipids and bisphosphonates and use ofthe compositions as bisphosphate delivery systems with reduced gi toxicity
US6471968B1 (en) 2000-05-12 2002-10-29 Regents Of The University Of Michigan Multifunctional nanodevice platform
US6548264B1 (en) 2000-05-17 2003-04-15 University Of Florida Coated nanoparticles
US6565873B1 (en) 2000-10-25 2003-05-20 Salvona Llc Biodegradable bioadhesive controlled release system of nano-particles for oral care products
EP1390404A2 (en) 2000-12-21 2004-02-25 Novartis AG Interleukin-1 related gene and protein
US20020127224A1 (en) 2001-03-02 2002-09-12 James Chen Use of photoluminescent nanoparticles for photodynamic therapy
WO2002088148A1 (en) 2001-04-30 2002-11-07 The Regents Of The University Of Michigan Isoreticular metal-organic frameworks, process for forming the same, and systematic design of pore size and functionality therein,with application for gas storage
AU2003226082A1 (en) 2002-03-25 2003-11-11 The General Hospital Corporation Methods of adjuvant photodynamic therapy to enhance radiation sensitization
CA2499955A1 (en) 2002-09-28 2004-04-08 Mcneil-Ppc, Inc. Delayed release dosage forms
BR0314787A (pt) * 2002-09-28 2005-07-26 Mcneil Ppc Inc Forma de dosagem de liberação modificada
EP1567169A4 (en) 2002-11-04 2009-10-21 Xenoport Inc GEMCITABINE PROMOTERS, THEIR PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
KR100401335B1 (en) 2003-03-08 2003-10-10 Mijitech Co Ltd Metal nanoparticle surface-coated with silicon oxides and preparation thereof
US6878838B2 (en) * 2003-03-24 2005-04-12 The University Of North Carolina At Chapel Hill Chiral porous metal phosphonates for heterogeneous asymmetric catalysis
WO2004084871A1 (en) 2003-03-26 2004-10-07 Ltt Bio-Pharma Co., Ltd. Intravenous nanoparticles for targenting drug delivery and sustained drug release
WO2004089345A1 (en) * 2003-04-03 2004-10-21 Semafore Pharmaceuticals Inc. Bone targeting of biodegradable drug-containing nanoparticles
EP1633760B1 (en) 2003-05-09 2010-05-05 The Regents of The University of Michigan MOFs with a high surface area and methods for producing them
EP1644388A2 (en) * 2003-06-27 2006-04-12 ODANI, Akira Bisphosphonate complexes
CA2534042A1 (en) 2003-07-31 2005-02-10 3M Innovative Properties Company Compositions for encapsulation and controlled release
CN1874789A (zh) 2003-09-23 2006-12-06 光科学公司 用于光动力疗法的缀合物
US20050227929A1 (en) 2003-11-13 2005-10-13 Masferrer Jaime L Combination therapy comprising a Cox-2 inhibitor and an antineoplastic agent
US20050147963A1 (en) 2003-12-29 2005-07-07 Intel Corporation Composite organic-inorganic nanoparticles and methods for use thereof
WO2005092195A1 (ja) 2004-03-29 2005-10-06 National Institute Of Radiological Sciences ヒール効果補正フィルタ、x線照射装置、x線ct装置及びx線ct撮像方法
US20070259966A1 (en) 2004-04-22 2007-11-08 Allos Therapeutics, Inc. Coadministration of Radiation, Efaproxiral Sodium, and Supplemental Oxygen for the Treatment of Cancer
FR2869803B1 (fr) 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
FR2874016B1 (fr) 2004-06-30 2006-11-24 Centre Nat Rech Scient Cnrse Nanoparticules de derives de la gemcitabine
US7964571B2 (en) 2004-12-09 2011-06-21 Egen, Inc. Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
US20070218049A1 (en) 2006-02-02 2007-09-20 Wei Chen Nanoparticle based photodynamic therapy and methods of making and using same
CA2597699C (en) 2005-02-17 2012-07-31 Hadasit Medical Research Services And Development Ltd. Bisphosphonates for treating endometriosis
CN1305937C (zh) 2005-02-25 2007-03-21 复旦大学 一种金属配位聚合物纳米结构材料的制备方法
US8158153B2 (en) * 2005-03-17 2012-04-17 Alkermes Pharma Ireland Limited Nanoparticulate bisphosphonate compositions
NO322682B1 (no) 2005-03-18 2006-11-27 Clavis Pharma Asa Anvendelse av gemcitabinderivater for fremstilling av orale doseringsformer ved kreftbehandling, samt slike orale doseringsformer
PE20070360A1 (es) 2005-09-01 2007-04-19 Novartis Ag Composiciones de liposomas
US20080095699A1 (en) 2006-10-20 2008-04-24 Shiying Zheng Imaging contrast agents using nanoparticles
US7263170B2 (en) 2005-09-30 2007-08-28 Pellegrino Anthony J Radiation therapy system featuring rotatable filter assembly
US20070088161A1 (en) * 2005-10-19 2007-04-19 Stockel Richard F Novel chelated bisphosphonates for use as pharmaceutical agents
WO2007090295A1 (en) 2006-02-09 2007-08-16 Simon Fraser University Birefringent metal-containing coordination polymers
US20100189222A1 (en) 2006-02-16 2010-07-29 Steller Micro Devices Panoramic irradiation system using flat panel x-ray sources
KR100943923B1 (ko) 2006-03-17 2010-02-24 홍순해 킬레이팅 유기 고분자와 생물학적 금속으로 이루어진 나노입자, 그리고 epr 효과를 이용한 새로운 광범위 무독성항암제 및 그 제조 방법
US20090317335A1 (en) 2006-04-20 2009-12-24 Wenbin Lin Hybrid Nanomaterials as Multimodal Imaging Contrast Agents
GB0613362D0 (en) 2006-07-05 2006-08-16 Hemocorm Ltd Therapeutic delivery of carbon monoxide
WO2008010263A1 (fr) 2006-07-18 2008-01-24 Mitsubishi Electric Corporation Procédé de production d'une électrode pour le traitement de surface par décharge et procédé de traitement de surface par décharge
US7699099B2 (en) * 2006-08-02 2010-04-20 B.J. Services Company, U.S.A. Modified Christmas tree components and associated methods for using coiled tubing in a well
WO2008016172A1 (fr) * 2006-08-04 2008-02-07 Kurume University Inhibiteur de métastase
US7985868B1 (en) 2006-11-01 2011-07-26 Sandia Corporation Hybrid metal organic scintillator materials system and particle detector
US20080124281A1 (en) 2006-11-29 2008-05-29 Board Of Regents, The University Of Texas System Nanotubular probes as ultrasensitive mr contrast agent
FR2910009B1 (fr) 2006-12-19 2009-03-06 Commissariat Energie Atomique Procede de preparation d'un film organique a la surface d'un support solide dans des conditions non-electrochimiques, su pport solide ainsi obtenu et kit de preparation
WO2008102632A1 (ja) 2007-02-21 2008-08-28 Konica Minolta Medical & Graphic, Inc. X線バンドパスフィルタ、x線照射システム及びx線撮影システム
JP2010523595A (ja) 2007-04-04 2010-07-15 マサチューセッツ インスティテュート オブ テクノロジー ポリ(アミノ酸)ターゲッティング部分
KR20090001013A (ko) 2007-06-29 2009-01-08 주식회사 웰스킨 인돌-3-알킬카복실산을 함유하는 여드름 치료제 및 피지분비 억제제, 및 이를 포함하는 광역학적 치료용 키트
EP2177525A1 (en) * 2007-07-06 2010-04-21 TMRC Co., Ltd. Metal complex compound, cancer therapeutic composition comprising the metal complex compound as active ingredient, and intermediate for production of the metal complex compound
US8486452B2 (en) 2007-07-20 2013-07-16 Mylan Pharmaceuticals Inc. Stabilized tolterodine tartrate formulations
ES2713194T3 (es) 2007-09-25 2019-05-20 Univ California Entramados organometálicos comestibles y biocompatibles
FR2921838A1 (fr) * 2007-10-05 2009-04-10 Guerbet Sa Nouveau procede de preparation de nanoparticules recouvertes d'une couche stabilisatrice gem-bisphosphonate couplee a des ligands de biodistribution hydrophile
WO2009139939A2 (en) 2008-02-22 2009-11-19 The University Of North Carolina At Chapel Hill Hybrid nanoparticles as anti-cancer therapeutic agents and dual therapeutic/imaging contrast agents
WO2009114476A1 (en) 2008-03-12 2009-09-17 Intradigm Corporation Compositions comprising survivin sirna and methods of use thereof
GB0807862D0 (en) 2008-04-29 2008-06-04 Uni I Oslo Compounds
US8968705B2 (en) 2008-08-22 2015-03-03 Colorado School Of Mines Gold/lanthanide nanoparticle conjugates and uses thereof
CA2994066A1 (en) 2008-12-03 2010-06-10 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase c agonists and methods of use
EP2198885B1 (en) 2008-12-19 2012-02-08 Biolitec AG Calcium phosphate nanoparticles as dye carrier for photodynamic therapy
WO2010121368A1 (en) 2009-04-24 2010-10-28 Socpra - Sciences Santé Et Humaines Compositions comprising a radiosensitizer and an anti-cancer agent and methods of uses thereof
WO2010136168A2 (en) 2009-05-25 2010-12-02 Merck Patent Gmbh Continuous administration of integrin ligands for treating cancer
US8933058B2 (en) * 2009-06-05 2015-01-13 Nanyang Technological University Targetted drug delivery to the bone
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions
WO2011049743A1 (en) 2009-10-06 2011-04-28 Stellarray, Inc. Self contained irradiation system using flat panel x-ray sources
JP5781518B2 (ja) 2009-10-16 2015-09-24 ユニバーシティ・ヘルス・ネットワーク ポルフィリンナノ小胞
MX2012005677A (es) 2009-11-20 2012-08-23 Clavis Pharma Asa Formulaciones parentales de derivados de gemcitabina.
GB201013307D0 (en) 2010-08-09 2010-09-22 Univ St Andrews Anti-microbial metal organic framework
IT1401882B1 (it) * 2010-10-01 2013-08-28 Rosa De Nanoparticelle autoassemblanti per il rilascio di bifosfonati nel trattamento di tumori.
WO2012138419A1 (en) 2011-04-04 2012-10-11 Georgia Tech Research Corporation Mof nanocrystals
NO2694640T3 (enExample) 2011-04-15 2018-03-17
US20120301537A1 (en) 2011-05-23 2012-11-29 Delta-Fly Pharma, Inc. LIPOSOME CONTAINING shRNA MOLECULE TARGETING A THYMIDYLATE SYNTHASE AND USE THEREOF
EP2717857B1 (en) 2011-06-06 2018-07-11 University Health Network (UHN) Method for the synthesis of porphyrin-phospholipid conjugates
WO2012174379A2 (en) 2011-06-16 2012-12-20 University Of South Florida Polyhedral cage-containing metalloporphyrin frameworks, methods of making, and methods of using
JP6049712B2 (ja) 2011-07-08 2016-12-21 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒルThe University Of North Carolina At Chapel Hill 抗癌治療及び画像化並びに骨障害治療のための金属ビスホスホネートナノ粒子
WO2013012628A2 (en) 2011-07-15 2013-01-24 The University Of Georgia Research Foundation, Inc. Immune-stimulating photoactive hybrid nanoparticles
WO2013027222A1 (en) 2011-08-23 2013-02-28 Yeda Research And Development Co.Ltd. (bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorders
CN102432654A (zh) 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
WO2013068965A2 (en) 2011-11-11 2013-05-16 Koninklijke Philips Electronics N.V. Lighting apparatus and manufacturing method for manufacturing the lighting apparatus
SG11201403096VA (en) 2011-12-16 2014-07-30 Nanobiotix Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
US20130209755A1 (en) 2012-02-15 2013-08-15 Phillip Dene Hustad Self-assembled structures, method of manufacture thereof and articles comprising the same
CN104582732A (zh) 2012-06-15 2015-04-29 布里格姆及妇女医院股份有限公司 治疗癌症的组合物及其制造方法
ES2721168T3 (es) 2013-01-11 2019-07-29 Dingfu Biotarget Co Ltd Agentes para tratar tumores, uso y método de los mismos
US10350275B2 (en) 2013-09-21 2019-07-16 Advantagene, Inc. Methods of cytotoxic gene therapy to treat tumors
CN105873569B (zh) 2013-11-06 2020-07-28 芝加哥大学 用于化疗剂、核酸和光敏剂的递送或共递送的纳米级载体
WO2015149072A1 (en) 2014-03-28 2015-10-01 The University Of Chicago Metal-organic frameworks containing nitrogen-donor ligands for efficient catalytic organic transformations
US10118169B2 (en) 2014-03-28 2018-11-06 The University Of Chicago Chiral ligand-based metal-organic frameworks for broad-scope asymmetric catalysis
US10806694B2 (en) 2014-10-14 2020-10-20 The University Of Chicago Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof
JP6731404B2 (ja) 2014-10-14 2020-07-29 ザ ユニバーシティ オブ シカゴThe University Of Chicago 光線力学療法、x線誘起光線力学療法、放射線療法、化学療法、免疫療法、及びこれらの任意の組み合わせのためのナノ粒子
US20180214563A1 (en) 2015-07-31 2018-08-02 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Immunostimulatory nanocarrier
US10953393B2 (en) 2015-10-12 2021-03-23 The University Of Chicago Stabilization of active metal catalysts at metal-organic framework nodes for highly efficient organic transformations
CN105457038A (zh) 2015-11-09 2016-04-06 东南大学 一种速释型药物磷脂化合物及其药物组合物
US11246877B2 (en) 2016-05-20 2022-02-15 The University Of Chicago Nanoparticles for chemotherapy, targeted therapy, photodynamic therapy, immunotherapy, and any combination thereof
CN109562355A (zh) 2016-08-18 2019-04-02 芝加哥大学 用于高效有机转化的金属氧化物负载的地球丰富的金属催化剂
US11826426B2 (en) 2017-08-02 2023-11-28 The University Of Chicago Nanoscale metal-organic layers and metal-organic nanoplates for x-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof
US20190314324A1 (en) 2018-04-13 2019-10-17 The University Of Chicago Combination of micheliolide derivatives or nanoparticles with ionizing radiation and checkpoint inhibitors for cancer therapy
US12042788B2 (en) 2019-08-21 2024-07-23 The University Of Chicago Strongly Lewis acidic metal-organic frameworks for continuous flow catalysis
JP2023526501A (ja) 2020-05-22 2023-06-21 ザ・ユニバーシティ・オブ・シカゴ 金属有機構造体が癌免疫療法の為の低分子及びバイオ高分子を送達する

Similar Documents

Publication Publication Date Title
JP2014520849A5 (enExample)
JP2019523757A5 (enExample)
USRE48510E1 (en) Phosphorus functional antimicrobial coatings for metal surfaces
JP6049712B2 (ja) 抗癌治療及び画像化並びに骨障害治療のための金属ビスホスホネートナノ粒子
EP3158867B1 (en) A method for increasing the aqueous solubility of a bisphosphonic acid or a bisphosphonate
JP2004528340A5 (enExample)
JP2006506365A5 (enExample)
JP2016536318A5 (enExample)
JP2013523751A5 (enExample)
JP2019512478A5 (enExample)
JP2012500197A5 (enExample)
JP2010535180A5 (enExample)
JP2017536344A5 (enExample)
Tusek–Bozic Aminophosphonate metal complexes of biomedical potential
US20140086979A1 (en) Self-Assembling Nanoparticles for the Release of Bisphosphonates in the Treatment of Human Cancers
JP2009522369A5 (enExample)
JP2018530582A5 (enExample)
JP2006500401A5 (enExample)
JP2006525368A5 (enExample)
JP2015502946A5 (enExample)
RU2004105144A (ru) Комбинации, включающие эпотилоны, и их фармацевтическое применение
US20090074833A1 (en) Bridged polycyclic compound based compositions for controlling bone resorption
JP2018530623A5 (enExample)
JP2013513632A5 (enExample)
US7455856B2 (en) Lipid-derivatized bisphosphonic acid